Colorectal Cancer Awareness Month: Finding Help with Medication Costs

Last Updated on March 17, 2026

March 2026

Colorectal cancer is the second leading cause of cancer death in the United States — and it is now the leading cause of cancer-related death among men and women under age 50. During National Colorectal Cancer Awareness Month, we want to make sure patients and caregivers know that help is available, especially when it comes to affording the medications that treat this disease.

At NeedyMeds, we maintain a free database of patient assistance programs, discount options, and financial resources that can help reduce your out-of-pocket costs. Here’s a guide to finding help for commonly prescribed colorectal cancer medications.

Chemotherapy: The Foundation of Treatment

Most colorectal cancer treatment plans include chemotherapy, often as part of combination regimens like FOLFOX or FOLFIRI. These drugs have been used for decades and remain central to care at every stage.

Xeloda (capecitabine) — An oral chemotherapy tablet that the body converts to fluorouracil; widely used for colorectal cancer

Eloxatin (oxaliplatin) — Commonly paired with capecitabine or other agents in the FOLFOX regimen

Camptosar (irinotecan) — Used in the FOLFIRI regimen, often for metastatic disease

Targeted Therapies

For patients with advanced or metastatic colorectal cancer, targeted therapies are often added to chemotherapy based on tumor biomarker testing. These drugs can be among the most expensive in oncology.

Erbitux (cetuximab) — An EGFR inhibitor used for advanced colorectal cancer, given by IV

Vectibix (panitumumab) — Another EGFR inhibitor for wild-type RAS metastatic colorectal cancer

Immunotherapy

For patients whose tumors have specific genetic features — microsatellite instability-high (MSI-H) or mismatch repair deficiency (dMMR) — immunotherapy checkpoint inhibitors have become a powerful treatment option.

Keytruda (pembrolizumab) — Approved as a first-line treatment for eligible colorectal cancer patients with MSI-H or dMMR tumors

Opdivo (nivolumab) — Another checkpoint inhibitor approved for metastatic colorectal cancer with MSI-H or dMMR

Yervoy (ipilimumab) — Used in combination with Opdivo for eligible patients

Later-Line Treatment Options

Stivarga (regorafenib) — An oral targeted therapy for metastatic colorectal cancer that has progressed on other treatments

Lonsurf (trifluridine/tipiracil) — An oral chemotherapy combination option for metastatic disease after prior therapies

Financial Assistance Programs for Colorectal Cancer Patients

Beyond medication-specific programs, several organizations offer broader financial support for people living with colorectal cancer.

Diagnosis-Based Assistance Programs

NeedyMeds maintains a dedicated list of organizations that provide financial assistance specifically for colorectal cancer patients — including help with copays, treatment costs, and other expenses.

More Ways NeedyMeds Can Help

Our resources go beyond what’s listed here. Use these tools to find additional assistance:

A colorectal cancer diagnosis is overwhelming — and the cost of treatment shouldn’t add to that burden. This Colorectal Cancer Awareness Month, take a few minutes to explore the resources available to you. You might be surprised at how much help is out there.

All NeedyMeds resources are free to use. We’re a 501(c)(3) nonprofit organization dedicated to helping people afford their medications and healthcare costs.

About Me

Related Posts

About Us

Welcome to the NeedyMeds Voice! We look forward to presenting you with timely, provocative pieces on healthcare reform, patient advocacy, medication and healthcare access, and other health-related news. Our goals are to educate, enlighten, and elucidate; together, we will try to make sense of the myriad and ongoing healthcare-related changes in the U.S. today.